These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5782692)

  • 1. [Studies on the therapy of uremic osteopathy].
    Schaefer K; Schaefer P; Koeppe P; Opitz A; Höffler D
    Dtsch Med Wochenschr; 1969 Jan; 94(2):70-2. PubMed ID: 5782692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the problem of uremic osteopathy. Intestinal calcium absorption disorders in relation to kidney function].
    Schaefer K; Schaefer P; Koeppe P; Opitz A; Höffler D
    Dtsch Med Wochenschr; 1968 May; 93(20):1018-22. PubMed ID: 5648078
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental renal osteopathy.
    Krempien B; Ritz E
    Isr J Med Sci; 1971 Mar; 7(3):522-4. PubMed ID: 5567547
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
    Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the therapy of uremic osteopathy].
    Schaefer K; Schaefer P; Koeppe P; Opitz A; Höffler D
    Verh Dtsch Ges Inn Med; 1968; 74():451-4. PubMed ID: 5714365
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disorders of hemostasis and blood coagulation during uremia. 3. Role of platelet anomalies and action of hemodialysis and renal grafts].
    Moriau M
    Pathol Eur; 1966; 1(1):273-97. PubMed ID: 4865670
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamine D3 and 25-hydroxycholecalciferol therapy in renal osteopathy: influence on serum calcium, phosphate, calcium phosphate products and on intestinal calcium absorption].
    Henning HV; Hesch RD; Hüsken WS; Quellhorst E; Scheler F
    Verh Dtsch Ges Inn Med; 1972; 78():1446-8. PubMed ID: 4665578
    [No Abstract]   [Full Text] [Related]  

  • 10. The nature of vitamin D resistance in experimental uremia.
    Kimberg DV; Baerg RD; Gershon E
    Arch Intern Med; 1970 Nov; 126(5):891-5. PubMed ID: 4319936
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of aluminum hydroxide on serum calcium, serum phosphorus and calcium turnover in uremic patients].
    Friis T; Weeke E
    Nord Med; 1969 Sep; 82(37):1136-42. PubMed ID: 5354523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of calcium metabolism in kidney failure].
    Ritz E; Krempien B; Andrassy K
    Med Klin; 1972 Sep; 67(36):1129-32. PubMed ID: 4561354
    [No Abstract]   [Full Text] [Related]  

  • 13. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of uraemic osteopathy.
    Schaefer K; Schaefer P; Koeppe P; Opitz A; Höffler D
    Ger Med Mon; 1969 May; 14(5):238-40. PubMed ID: 5820140
    [No Abstract]   [Full Text] [Related]  

  • 15. [Uremic osteopathy in chronic nephritis].
    Sakal V; Sakalová A
    Z Urol Nephrol; 1970 Jan; 63(1):21-5. PubMed ID: 5523612
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.
    Wong RG; Norman AW; Reddy CR; Coburn JW
    J Clin Invest; 1972 May; 51(5):1287-91. PubMed ID: 4341503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azotemic renal osteodystrophy.
    Baker J; Anderson KC; Ross G
    Mo Med; 1966 Oct; 63(10):807-10. PubMed ID: 5976677
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium absorption in renal failure: its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables.
    Recker RR; Saville PD
    J Lab Clin Med; 1971 Sep; 78(3):380-8. PubMed ID: 5092859
    [No Abstract]   [Full Text] [Related]  

  • 19. [A simple method for the prediction of the time of onset of uremia in patients with chronic kidney failure].
    Kleint V; Stradtmann H
    Z Gesamte Inn Med; 1978 Nov; 33(21):789-92. PubMed ID: 735252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of renal osteodystrophy with 25-hydroxycholecalciferol.
    DeLuca HF; Avioli LV
    Arch Intern Med; 1970 Nov; 126(5):896-9. PubMed ID: 4319937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.